Pharmaceutical Technology's In the Lab eNewsletter
Katalyst D2D from ACD/Labs enables the design, planning, execution, and analysis of high throughput (HT) experiments. The web-based application was introduced at Pittcon 2019 in Philadelphia, PA.
ACD/Labs, an informatics company that provides analytical and chemical knowledge management solutions for R&D, has developed the Katalyst D2D, a new web-based application for high throughput (HT) experimentation.
Katalyst D2D offers a single interface for HT experimentation and parallel synthesis, from experimental design to final decisions. The company reports that the interface supports the digitization of laboratory tasks, integration with existing informatics systems, lab automation hardware, analytical instrumentation, and automated execution.
The app’s digital environment eliminates the manual transcription currently necessary between systems, as well as the process of gathering and interpreting associated analytical data. This function helps promote data integrity in HT experimentation for reaction optimization, process development, catalyst screening, and scale-up. By streamlining HT workflows, organizations are able to optimize laboratory efficiency, the analysis of array-based chemistry, and the return on investment in HT robotic equipment, according to the company.
Other features include:
The application was showcased for the first time at booth 2116 at Pittcon 2019, Philadelphia, PA, March 17–21, 2019.
Source: ACD/Labs
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.